SCHEMBL26289550

SCHEMBL26289550

CCC(CC)COC(=O)[C@H](C)NP(=O)(N[C@@H](C)C(=O)OC1CCCCC1)OCC(C#N)(OC)[C@@H](O)[C@@H](O)c1ccc2c(N)ncnn12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23818637 0.90 — —
SCHEMBL23819113 0.90 — —
SCHEMBL23819285 0.86 RIPK1 (0.31) —
SCHEMBL23819068 0.85 BTN3A1 (0.34) —
SCHEMBL26291688 0.85 BTN3A1 (0.34) —
SCHEMBL26295572 0.85 EGLN2 (0.31) —
SCHEMBL23819284 0.85 RIPK1 (0.33) —
SCHEMBL23818627 0.85 RIPK1 (0.33) —
SCHEMBL26290919 0.85 BTN3A1 (0.35) —
SCHEMBL23818486 0.84 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295201-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. 2023-09-21 — — US disclosed
Send feedback